Doc, Great find:

New Post Public Reply Private Reply Replies (1) Message Board
Assiduous docj #20698
330
Doc, Great find: https://www.yahoo.com/news/mind-bogglingly-co...58439.html

With the flawless way our government has performed over the last 3½ years, what could possibly go wrong?

The Covid vaccine protocols are sufficiently different from the standard flu shipping/storage methods (2008). https://www.naccho.org/uploads/downloadable-r...-MDH-3.pdf

So my questions are:
What is the acceptable temperature variance for the Covid vaccine? 1%? 10%?
What happens if the vaccine goes undetected out of the temperature tolerance and then is administered? Just ineffective? Patient health consequences?
What is the second shot window variance of opportunity? 1day? 5 days?
What happens to the efficiency if the second shot is late/early or not given? Ineffective vaccine? Patient side effects? Mild? Serious?
What is the exposure risk between the first and second vaccine shot?
What are the protocols for adverse patient reactions? Are the common side effects , both immediate and delayed, been documented?
For the uninsured vaccine recipients, who pays for adverse reactions/side effects follow-up medical care/procedures?
Will the patient have a choice of which vaccine to take? Will the effectiveness and side effects of each vaccine be made public for an informed decision/consent?

As the proverb goes; “Fools rush in where angels fear to tread.” Do the angles even know the answers?

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

PotlatchDeltic Reveals Tax Implications for 2024 Shareholder Dividends

Updated Category News Views 247

PotlatchDeltic Reveals Dividend Tax Treatment for 2024 PotlatchDeltic Corporation (Nasdaq: PCH) is stepping into the spotlight by announcing the tax treatment for its anticipated dividend distributions throughout the year. As a prominent player in the real estate investment sector, this announcement brings clarity to investors regarding how dividends will be categorized...

Continue Reading
Beyond Air Secures $3.25 Million from Warrant Exercises

Updated Category News Views 158

Beyond Air's Strategic Moves to Boost Capital Beyond Air, Inc. (NASDAQ: XAIR), a leading medical device and biopharmaceutical company, is making waves in the financial realm. Focused on the innovative use of nitric oxide (NO) to enhance patient care, Beyond Air has announced the immediate exercise of certain outstanding warrants, aiming to generate approximately $3.25...

Continue Reading
Dr. Sven Kili Joins Saisei Ventures as New Partner

Updated Category News Views 194

Saisei Ventures Welcomes Dr. Sven Kili as Partner Saisei Ventures, a prominent investment firm focused on the advancement of biotechnology and therapeutic innovations, has announced an exciting new chapter in its journey. Dr. Sven Kili, MD, has been appointed as a partner, marking a significant addition to the team's leadership. Dr. Kili, who played an advisory role since...

Continue Reading
MangoRx Unveils Innovative Tirzepatide Tablet for Weight Loss

Updated Category News Views 192

Mangoceuticals, Inc. (NASDAQ: MGRX) launched its new oral Tirzepatide tablet, TRIM, back in 2024 at a steep price of $399 per month. Traders noticed this shift towards a convenient alternative to traditional injectables and were already debating the long-term implications on sales and market share. TRIM's Role: A Game Changer for Weight Management? Tirzepatide has made...

Continue Reading
Mama’s Creations Q2 FY2025 Earnings Call Announcement

Updated Category News Views 77

Mama’s Creations to Host Earnings Call for Second Quarter FY2025 Mama’s Creations, Inc. (NASDAQ: MAMA), a leading national marketer and manufacturer of fresh deli prepared foods, is preparing to announce its financial results for the fiscal second quarter, which ended on July 31. The earnings call is scheduled to take place after the market closes on September 10....

Continue Reading